AEON Biopharma, Inc. (AEON)Healthcare | Biotechnology | Irvine, United States | NYSE American
1.02 USD
+0.03
(3.239%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 0.99 -0.03 (-0.030%) ⇩ (April 17, 2026, 6:09 p.m. EDT) Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 1:18 p.m. EDT
AEON Biopharma is a high-risk short-term play with strong bearish signals, driven by deteriorating fundamentals, negative price momentum, and a lack of analyst coverage. The stock has been in a prolonged downtrend, with recent price action showing volatility and weakness. Long-term prospects are bleak due to poor financial health, negative earnings, and ongoing regulatory and compliance issues. There is no dividend, and the company's fundamentals suggest a high probability of continued underperformance. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.131987 |
| AutoARIMA | 0.132980 |
| MSTL | 0.141910 |
| AutoTheta | 0.230447 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 48% |
| H-stat | 5.05 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.308 |
| Excess Kurtosis | -0.63 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 25,809,120 |
| Forward P/E | -1.48 |
| Beta | 0.74 |
| Website | https://www.aeonbiopharma.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 1.55 |
| Address1 | 5 Park Plaza |
| Address2 | Suite 1750 |
| All Time High | 1,236.24 |
| All Time Low | 0.375 |
| Ask | 1.03 |
| Ask Size | 2,600 |
| Average Daily Volume10 Day | 186,900 |
| Average Daily Volume3 Month | 146,319 |
| Average Volume | 146,319 |
| Average Volume10Days | 186,900 |
| Beta | 0.735 |
| Bid | 1.01 |
| Bid Size | 700 |
| Book Value | -4.545 |
| City | Irvine |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.02 |
| Current Ratio | 0.493 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.067 |
| Day Low | 0.9799 |
| Display Name | AEON Biopharma |
| Ebitda | -16,224,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -3.609 |
| Enterprise Value | 58,548,120 |
| Eps Current Year | -1.96 |
| Eps Forward | -0.69 |
| Eps Trailing Twelve Months | -3.95 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.05122 |
| Fifty Day Average Change | -0.031220078 |
| Fifty Day Average Change Percent | -0.029698899 |
| Fifty Two Week Change Percent | 155.0 |
| Fifty Two Week High | 1.45 |
| Fifty Two Week High Change | -0.43000007 |
| Fifty Two Week High Change Percent | -0.29655176 |
| Fifty Two Week Low | 0.38 |
| Fifty Two Week Low Change | 0.64 |
| Fifty Two Week Low Change Percent | 1.6842105 |
| Fifty Two Week Range | 0.38 - 1.45 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,672,756,200,000 |
| Float Shares | 9,817,840 |
| Forward Eps | -0.69 |
| Forward P E | -1.4782609 |
| Free Cashflow | -10,995,750 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 8 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.88754 |
| Held Percent Institutions | 0.07783 |
| Implied Shares Outstanding | 25,303,059 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-10-14 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,740,528,000 |
| Last Split Factor | 1:72 |
| Long Business Summary | AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California. |
| Long Name | AEON Biopharma, Inc. |
| Market | us_market |
| Market Cap | 25,809,120 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_247856902 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -39,222,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 25,809,119 |
| Number Of Analyst Opinions | 2 |
| Open | 0.98 |
| Operating Cashflow | -17,308,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 949 354 6499 |
| Post Market Change | -0.029599965 |
| Post Market Change Percent | -2.9019573 |
| Post Market Price | 0.9904 |
| Post Market Time | 1,776,463,796 |
| Previous Close | 0.988 |
| Price Eps Current Year | -0.52040815 |
| Price Hint | 4 |
| Price To Book | -0.22442244 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.436 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.032 |
| Regular Market Change Percent | 3.23887 |
| Regular Market Day High | 1.067 |
| Regular Market Day Low | 0.9799 |
| Regular Market Day Range | 0.9799 - 1.067 |
| Regular Market Open | 0.98 |
| Regular Market Previous Close | 0.988 |
| Regular Market Price | 1.02 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 179,604 |
| Return On Assets | -2.3417 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 25,303,058 |
| Shares Percent Shares Out | 0.0057 |
| Shares Short | 144,810 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 209,615 |
| Short Name | AEON Biopharma, Inc. |
| Short Percent Of Float | 0.0057 |
| Short Ratio | 2.08 |
| Source Interval | 15 |
| State | CA |
| Symbol | AEON |
| Target High Price | 8.4 |
| Target Low Price | 5.0 |
| Target Mean Price | 6.7 |
| Target Median Price | 6.7 |
| Total Cash | 3,006,000 |
| Total Cash Per Share | 0.119 |
| Total Debt | 35,745,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.95 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.937445 |
| Two Hundred Day Average Change | 0.082554996 |
| Two Hundred Day Average Change Percent | 0.08806383 |
| Type Disp | Equity |
| Volume | 179,604 |
| Website | https://www.aeonbiopharma.com |
| Zip | 92,614 |